421 related articles for article (PubMed ID: 3308662)
1. [Significance of hormonal contraceptives for coronary heart disease].
Gohlke-Bärwolf C
Herz; 1987 Aug; 12(4):263-75. PubMed ID: 3308662
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular risk of oral contraceptives. Low, and mainly in women at risk.
Prescrire Int; 1998 Aug; 7(36):118-24. PubMed ID: 10342951
[TBL] [Abstract][Full Text] [Related]
3. [Cardiovascular risks of oral contraceptives: dose-response relationship].
Kelleher CC
Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
[TBL] [Abstract][Full Text] [Related]
4. [Combined contraceptives and cardiovascular risk].
Belaisch J; Hommais-loufrani B
Contracept Fertil Sex (Paris); 1987 Dec; 15(12 Suppl):1-8. PubMed ID: 12315199
[TBL] [Abstract][Full Text] [Related]
5. [Vascular disease and hormonal treatment--epidemiology].
Vessey MP
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):121-6. PubMed ID: 12280197
[TBL] [Abstract][Full Text] [Related]
6. Risks of oral contraceptive use in women over 35.
Stenchever MA
J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860
[TBL] [Abstract][Full Text] [Related]
7. The Royal College of General Practitioners' Oral Contraception Study: some recent observations.
Kay CR
Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858
[TBL] [Abstract][Full Text] [Related]
8. 30 years of change: the current perspective on cardiovascular risks and oral contraceptives.
Contracept Rep; 1995 May; 6(2):4-9, 14. PubMed ID: 12319497
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
[TBL] [Abstract][Full Text] [Related]
10. The risk of serious illness among oral contraceptive users: evidence from the RCGP's oral contraceptive study.
Hannaford PC; Kay CR
Br J Gen Pract; 1998 Oct; 48(435):1657-62. PubMed ID: 10071398
[TBL] [Abstract][Full Text] [Related]
11. Recommendations arising out of the findings by the RCGP oral contraception sutdy on the mortality risks of oral contraceptive users. From the Royal College of General Practitioners and the Royal College of Obstetricians nad Gynaecologists.
J R Coll Gen Pract; 1977 Nov; 27(184):700. PubMed ID: 616860
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular disease and steroid hormone contraception. Report of a WHO Scientific Group.
World Health Organ Tech Rep Ser; 1998; 877():i-vii, 1-89. PubMed ID: 9615606
[TBL] [Abstract][Full Text] [Related]
13. [Hormonal contraceptives and cardiovascular risk. Results of an East German multicenter case control study].
Meinel H; Göretzlehner G; Heinemann L
Zentralbl Gynakol; 1988; 110(23):1507-14. PubMed ID: 3071053
[TBL] [Abstract][Full Text] [Related]
14. [Cardiovascular risk factors and prevention in women: similarities and differences].
Sclavo M
Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
[TBL] [Abstract][Full Text] [Related]
15. A prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases.
Stampfer MJ; Willett WC; Colditz GA; Speizer FE; Hennekens CH
N Engl J Med; 1988 Nov; 319(20):1313-7. PubMed ID: 3185634
[TBL] [Abstract][Full Text] [Related]
16. Oral contraceptive risks: a realistic appraisal.
Bressler R; Durand JL
Drug Ther (NY); 1979 Oct; 9(10):81-95. PubMed ID: 12279276
[TBL] [Abstract][Full Text] [Related]
17. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
[TBL] [Abstract][Full Text] [Related]
18. [Myocardial infarction and oral contraceptives].
Bounhoure JP; Galinier M; Roncalli J; Assoun B; Puel J
Bull Acad Natl Med; 2008 Mar; 192(3):569-79; discussion 579. PubMed ID: 18819701
[TBL] [Abstract][Full Text] [Related]
19. [Oral contraception, glucid metabolism and monitoring criteria].
Gaspard U
Contracept Fertil Sex (Paris); 1988 Feb; 16(2):113-8. PubMed ID: 12342000
[TBL] [Abstract][Full Text] [Related]
20. [Oral contraceptives and cardiovascular diseases morbidity].
Lara Ricalde R; Aznar Ramos R
Ginecol Obstet Mex; 1986 May; 54():119-25. PubMed ID: 3732840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
